Jaguar Health (JAGX) Operating Expenses (2014 - 2026)
Jaguar Health (JAGX) posted quarterly Operating Expenses of $10.1 million for Q1 2026, down 13.28% year-over-year from $11.6 million in Q1 2025, and down 58.78% quarter-over-quarter from $24.5 million in Q4 2025.
Jaguar Health (JAGX) Operating Expenses (2014 - 2026) Analysis & Trends
Jaguar Health (JAGX) has reported Operating Expenses for 13 consecutive years, with $10.1 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses fell 13.28% year-over-year to $10.1 million; the TTM figure through Mar 2026 stood at $55.9 million (up 28.18% YoY), while the FY2025 annual figure was $57.4 million, up 35.04% from the prior year.
- Operating Expenses retreated to $10.1 million in Q1 2026 per JAGX's latest filing, from $24.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $24.5 million in Q4 2025 and bottomed at $9.4 million in Q2 2022.
- Historically, Operating Expenses has averaged $11.8 million across 5 years, with a median of $10.8 million in 2023.
- Annual changes were most pronounced in 2022 — Operating Expenses declined 26.01% — and 2025, when it jumped 109.81%.
- Jaguar Health's Operating Expenses stood at $9.5 million in 2022, then gained by 3.26% to $9.9 million in 2023, then grew by 18.35% to $11.7 million in 2024, then surged by 109.81% to $24.5 million in 2025, then sank by 58.78% to $10.1 million in 2026.
- Business Quant data shows JAGX's Operating Expenses at $10.1 million in Q1 2026, $24.5 million in Q4 2025, and $10.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Jaguar Health | 452,552.38 | -9.61 Mn | 19.11 Mn | 10.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.09 Mn |
| Dec 31, 2025 | 24.48 Mn |
| Sep 30, 2025 | 10.32 Mn |
| Jun 30, 2025 | 10.99 Mn |
| Mar 31, 2025 | 11.64 Mn |
| Dec 31, 2024 | 11.67 Mn |
| Sep 30, 2024 | 10.37 Mn |
| Jun 30, 2024 | 9.92 Mn |
| Mar 31, 2024 | 10.57 Mn |
| Dec 31, 2023 | 9.86 Mn |
| Sep 30, 2023 | 11.60 Mn |
| Jun 30, 2023 | 10.78 Mn |
| Mar 31, 2023 | 11.82 Mn |
| Dec 31, 2022 | 9.55 Mn |
| Sep 30, 2022 | 13.05 Mn |
| Jun 30, 2022 | 9.40 Mn |
| Mar 31, 2022 | 14.38 Mn |
| Dec 31, 2021 | 12.90 Mn |
| Sep 30, 2021 | 10.16 Mn |
| Jun 30, 2021 | 11.97 Mn |